HAP Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

HAP Trading’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,200	Closed	-$115K	–	2564
2022 Q1	$115K	Buy	25,200 +6,400	+34%	+$798K	﹤0.01%	1002
2021 Q4	$56K	Buy	+18,800	New	+$2.39M	﹤0.01%	1436
2021 Q1	–	Sell	-157,100	Closed	-$690K	–	2793
2020 Q4	$690K	Buy	+157,100	New	+$13.3M	0.02%	525
2019 Q3	–	Sell	-63,800	Closed	-$7K	–	1583
2019 Q2	$7K	Buy	63,800 +1,300	+2%	+$73.3K	﹤0.01%	1006
2019 Q1	$22K	Buy	+62,500	New	+$2.7M	﹤0.01%	817
2018 Q2	–	Sell	-30,100	Closed	-$23K	–	1258
2018 Q1	$23K	Buy	+30,100	New	+$900K	﹤0.01%	751

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HAP Trading's BHVN Position: Q1 2020 in Review

HAP Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 91,752 shares — an estimated $4.2M sold.

HAP Trading first reported a position in BHVN in Q1 2018 and held it in 3 quarters. The position peaked at $5M in Q4 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

HAP Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
HAP Trading sold 91,752 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $4.2M.
HAP Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 3 quarters.
HAP Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5M in Q4 2019.
175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on HAP Trading's 13F filing for Q1 2020, filed 8 May 2020.